Counselors in South El Monte, CA Accepting Medicare

5 Counselors found. Showing 1 - 5

Andrea Monique Hatfield Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Ave, South El Monte, CA 91733 Phone: 626-442-4788

Elvia Torres, M.F.T.. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Ave, South El Monte, CA 91733 Phone: 626-442-1400    Fax: 626-442-1144

Melissa Griggs, M.A. LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Ave, South El Monte, CA 91733 Phone: 626-442-1400    Fax: 626-448-3425

Marlene Romo, ASW Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Ave, South El Monte, CA 91733 Phone: 562-447-5015

Mrs. Perla Pelayo Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2000 Tyler Ave, South El Monte, CA 91733 Phone: 626-442-1400

News Archive

Children with NAFLD at substantial risk for high blood pressure

High blood pressure and nonalcoholic fatty liver disease (NAFLD) are two emerging health problems related to the epidemic of childhood obesity. In a recent study, researchers at University of California, San Diego School of Medicine sought to determine the prevalence of high blood pressure in children with NAFLD, which places them at risk for premature cardiovascular disease.

Muscle atrophy therapy: an interview with Dr. Levine, Clinical Associate Professor at Temple University School of Medicine

Atrophy is loss of muscle which can occur in response to either pain or trauma. When you stop using something like muscle it gets weaker.

Ardea's to present its hyperuricemia canditate study results at the ACR/ARHP Scientific Meeting

Ardea Biosciences, Inc. announced that it will present results from a Phase 2a, proof-of-concept study of RDEA594, its lead product candidate for the treatment of hyperuricemia and gout, at the 2009 American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting in Philadelphia, Pennsylvania.

Lpath achieves one of the four Phase 1 objectives by demonstrating its optimized fermentation process

Lpath, Inc., the category leader in lipidomics-based therapeutics, demonstrated commercially acceptable yields in its optimized fermentation process. In doing so, Lpath achieved one of four Phase 1 objectives established by Merck Serono, the exclusive worldwide licensee of ASONEP and Lpath's development partner, and will receive a milestone payment according to the terms of the Merck Serono license agreement.

Read more Medical News

› Verified 4 days ago